ArticleFrontiers in oncology2026
Case Report: Pulmonary benign metastasizing leiomyoma with mild
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Benign metastasizing leiomyoma (BML) is a rare smooth-muscle tumor that occurs in patients with a history of uterine leiomyoma, with the lungs being the most commonly involved extrauterine site. Pulmonary BML can mimic metastatic malignancy on imaging. Decades-long intervals after uterine surgery have been reported, and Case presentation: A 59-year-old postmenopausal, nonsmoking woman presented with multiple bilateral pulmonary nodules 30 years after hysterectomy for uterine leiomyoma. Conclusion: Pulmonary BML should be considered in the differential diagnosis of multiple pulmonary nodules in women with a remote history of uterine leiomyoma. Mild FDG uptake cannot distinguish pulmonary BML from a low-grade malignancy. Integrated clinical, radiological, and pathological assessment is therefore required to establish the diagnosis and avoid unnecessary treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.